Understanding how immune cells power themselves could unlock breakthroughs in treating antibiotic-resistant infections. When bacteria invade, our front-line defenders—macrophages—dramatically rewire their energy systems, but this metabolic makeover serves purposes far beyond generating cellular fuel.
Macrophages shift from efficient oxygen-dependent energy production to rapid sugar burning, fundamentally altering their immune response capabilities. This metabolic pivot activates pyruvate kinase M2, which directly influences inflammatory gene expression, while changing NAD+/NADH ratios determine whether cells trigger inflammasome responses or interferon pathways. The process generates immunoactive metabolites including lactate, succinate, and itaconate that modify proteins through novel mechanisms like histone lactylation—essentially rewriting cellular programming instructions.
Pathogens like Salmonella and tuberculosis bacteria have evolved sophisticated strategies to hijack these metabolic networks, effectively turning the immune system's own energy machinery against itself. This represents a previously underappreciated battlefield where infections are won or lost at the molecular level.
This metabolic-immune axis opens entirely new therapeutic possibilities beyond traditional antibiotics. Rather than directly attacking bacteria, treatments could enhance macrophage metabolic programming or block pathogen exploitation of host energy systems. Such approaches could prove especially valuable against persistent infections that resist conventional drugs. However, translating these cellular insights into clinical interventions requires careful navigation of complex metabolic interdependencies that affect multiple organ systems. The framework nonetheless provides a promising foundation for next-generation antimicrobial strategies targeting the host-pathogen metabolic interface.